These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 10657039

  • 1. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y, Mitsushio H, Takahashi K, Nishikawa T.
    Synapse; 2000 Mar 15; 35(4):292-9. PubMed ID: 10657039
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A, Takahashi K, Nishikawa T.
    Br J Pharmacol; 1998 May 15; 124(2):377-85. PubMed ID: 9641556
    [Abstract] [Full Text] [Related]

  • 3. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M.
    Brain Res; 2004 Jun 11; 1011(1):84-93. PubMed ID: 15140647
    [Abstract] [Full Text] [Related]

  • 4. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC.
    Neurochem Int; 2008 Jan 11; 52(1-2):119-29. PubMed ID: 17716783
    [Abstract] [Full Text] [Related]

  • 5. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
    Dawson NM, Hamid EH, Egan MF, Meredith GE.
    Synapse; 2001 Jan 11; 39(1):70-81. PubMed ID: 11071712
    [Abstract] [Full Text] [Related]

  • 6. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.
    Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ.
    J Psychopharmacol; 2006 Sep 11; 20(5):636-42. PubMed ID: 16478754
    [Abstract] [Full Text] [Related]

  • 7. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A, Noda Y, Noda A, Nakamura T, Tokura T, Yura Y, Nitta A, Furukawa H, Nabeshima T.
    Mol Pharmacol; 2007 Jun 11; 71(6):1598-609. PubMed ID: 17344353
    [Abstract] [Full Text] [Related]

  • 8. Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain.
    Semba J, Tanaka N, Wakuta M, Suhara T.
    Synapse; 2001 Apr 11; 40(1):11-8. PubMed ID: 11170217
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1985 Oct 11; 235(1):50-7. PubMed ID: 2864436
    [Abstract] [Full Text] [Related]

  • 10. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K, Nguyen V, Newell K, Ballantyne P, Huang XF.
    J Chem Neuroanat; 2008 Oct 11; 36(2):71-6. PubMed ID: 18640263
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of neuropeptide Y systems in limbic structures of the rat.
    Midgley LP, Bush LG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1993 Nov 11; 267(2):707-13. PubMed ID: 8246145
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
    Ding XZ, Mocchetti I.
    J Pharmacol Exp Ther; 1992 Oct 11; 263(1):368-73. PubMed ID: 1403798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat.
    Riegel AC, Ali SF, Torinese S, French ED.
    Ann N Y Acad Sci; 2004 Oct 11; 1025():543-51. PubMed ID: 15542760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P, Lypko A, Szczudlik A, Libich J.
    Pol J Pharmacol Pharm; 1981 Oct 11; 33(5):499-502. PubMed ID: 6174959
    [Abstract] [Full Text] [Related]

  • 17. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
    Schmidt CJ, Fadayel GM.
    J Pharmacol Exp Ther; 1996 Jun 11; 277(3):1541-9. PubMed ID: 8667221
    [Abstract] [Full Text] [Related]

  • 18. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment.
    Hanson GR, Midgley LP, Bush LG, Gibb JW.
    Eur J Pharmacol; 1995 May 15; 278(2):167-73. PubMed ID: 7672001
    [Abstract] [Full Text] [Related]

  • 19. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
    Jentsch JD, Wise A, Katz Z, Roth RH.
    Synapse; 1998 Jan 15; 28(1):21-6. PubMed ID: 9414014
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.